Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy: Year of treatment an independent predictor of outcomeKUPELIAN, Patrick A; BUCHSBALIM, Jeffrey C; ELSHAIKH, Mohamed A et al.International journal of radiation oncology, biology, physics. 2003, Vol 57, Num 3, pp 629-634, issn 0360-3016, 6 p.Article

OUTCOME AFTER CONFORMAL SALVAGE RADIOTHERAPY IN PATIENTS WITH RISING PROSTATE-SPECIFIC ANTIGEN LEVELS AFTER RADICAL PROSTATECTOMYGEINITZ, Hans; RIEGEL, Martina G; THAMM, Reinhard et al.International journal of radiation oncology, biology, physics. 2012, Vol 82, Num 5, pp 1930-1937, issn 0360-3016, 8 p.Article

Outcomes and predictive factors for biochemical relapse following primary androgen deprivation therapy in men with bone scan negative prostate cancerHORI, S; JABBAR, T; KACHROO, N et al.Journal of cancer research and clinical oncology. 2011, Vol 137, Num 2, pp 235-241, issn 0171-5216, 7 p.Article

The Impact of the Extent of Lymph-node Dissection on Biochemical Relapse after Radical Prostatectomy in Node-negative PatientsSCHIAVINA, Riccardo; BERTACCINI, Alessandro; FRANCESCHELLI, Alessandro et al.Anticancer research. 2010, Vol 30, Num 6, pp 2297-2302, issn 0250-7005, 6 p.Article

HIGH-DOSE-RATE BRACHYTHERAPY ALONE FOR LOCALIZED PROSTATE CANCER IN PATIENTS AT MODERATE OR HIGH RISK OF BIOCHEMICAL RECURRENCEHOSKIN, Peter; ROJAS, Ana; LOWE, Gerry et al.International journal of radiation oncology, biology, physics. 2012, Vol 82, Num 4, pp 1376-1384, issn 0360-3016, 9 p.Article

Does a tertiary Gleason pattern 4 or 5 influence the risk of biochemical relapse after radical prostatectomy for clinically localized prostate cancer?SERVOLL, Einar; SÆTER, Thorstein; VLATKOVIC, Ljiljana et al.Scandinavian journal of urology and nephrology. 2010, Vol 44, Num 4, pp 217-222, issn 0036-5599, 6 p.Article

Phase 2 study of granulocyte-macrophage colony-stimulating factor plus thalidomide in patients with hormone-naïve adenocarcinoma of the prostatesAMATO, Robert J; HERNANDEZ-MCCLAIN, Joan; HENARY, Haby et al.Urologic oncology. 2009, Vol 27, Num 1, pp 8-13, issn 1078-1439, 6 p.Article

TWICE-WEEKLY HYPOFRACTIONATED INTENSITY-MODULATED RADIOTHERAPY FOR LOCALIZED PROSTATE CANCER WITH LOW-RISK NODAL INVOLVEMENT: TOXICITY AND OUTCOME FROM A DOSE ESCALATION PILOT STUDYZILLI, Thomas; JORCANO, Sandra; LINERO, Dolors et al.International journal of radiation oncology, biology, physics. 2011, Vol 81, Num 2, pp 382-389, issn 0360-3016, 8 p.Article

Prognostic significance of prostate cancer originating from the transition zoneKING, Christopher R; FERRARI, Michelle; BROOKS, James D et al.Urologic oncology. 2009, Vol 27, Num 6, pp 592-597, issn 1078-1439, 6 p.Article

Elective Irradiation of Pelvic Lymph Nodes During Postprostatectomy Salvage RadiotherapyMOGHANAKI, Drew; KOONTZ, Bridget F; KARLIN, Jeremy D et al.Cancer. 2013, Vol 119, Num 1, pp 52-60, issn 0008-543X, 9 p.Article

Tissue Expression of ILI6 in Prostate Cancer and Its Association With Recurrence After Radical ProstatectomyCOMPERAT, Eva; ROUPRET, Morgan; DROUIN, Sarah J et al.The Prostate. 2010, Vol 70, Num 15, pp 1622-1627, issn 0270-4137, 6 p.Article

Population-Based 10-Year Oncologic Outcomes After Low-Dose-Rate Brachytherapy for Low-Risk and Intermediate-Risk Prostate CancerMORRIS, W. James; KEYES, Mira; SPADINGER, Ingrid et al.Cancer. 2013, Vol 119, Num 8, pp 1537-1546, issn 0008-543X, 10 p.Article

The extent of pelvic lymph node dissection correlates with the biochemical recurrence rate in patients with intermediate- and high-risk prostate cancerSCHIAVINA, Riccardo; MANFERRARI, Fabio; MARTORANA, Giuseppe et al.BJU international (Papier). 2011, Vol 108, Num 8, pp 1262-1268, issn 1464-4096, 7 p.Article

A phase II trial of imatinib mesylate in patients with biochemical relapse of prostate cancer after definitive local therapyLIN, Amy M; RINI, Brian I; WEINBERG, Vivian et al.BJU international (Papier). 2006, Vol 98, Num 4, pp 763-769, issn 1464-4096, 7 p.Article

miRNAs can predict prostate cancer biochemical relapse and are involved in tumor progressionFENDLER, Annika; JUNG, Monika; STEPHAN, Carsten et al.International journal of oncology. 2011, Vol 39, Num 5, pp 1183-1192, issn 1019-6439, 10 p.Article

The Change of PSA DoublingTime and Its Association With Disease Progression in Patients With Biochemically Relapsed Prostate Cancer Treated With Intermittent Androgen DeprivationKEIZMAN, Daniel; PENG HUANG; ANTONARAKIS, Emmanuel S et al.The Prostate. 2011, Vol 71, Num 15, pp 1608-1615, issn 0270-4137, 8 p.Article